Posttransplantation Lymphoproliferative Disease Treated by Retransplantation

Epstein–Barr virus- (EBV-) induced posttransplantation lymphoproliferative disease (PTLD) is a life-threatening complication following allogeneic stem cell transplantation. The main risk factor is anti-thymocyte globulin (ATG). Patients who fail first-line treatment with rituximab have a poor progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Weum Abrahamsen, Ingerid, Grønvold, Bjørn Christer, Inderberg, Else Marit, Mensali, Nadia, Mattsson, Jonas, Gedde-Dahl, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060862/
https://www.ncbi.nlm.nih.gov/pubmed/32158568
http://dx.doi.org/10.1155/2020/9403123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060862/
https://www.ncbi.nlm.nih.gov/pubmed/32158568
http://dx.doi.org/10.1155/2020/9403123

Ejemplares similares